menu
    • menu

    Company profile for Sosei Heptares

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sosei Heptares is an international biopharmaceutical group focused on the design and early development of new medicines originating from its proprietary GPCR-targeted StaR® technology and Structure-Based Drug Design platform capabilities. We are advancing a broad and deep pipeline of partnered and in-house drug candidates in multiple therapeutic areas including neurology, immuno-oncology, gastroenterology, inflammation and ra...
    Sosei Heptares is an international biopharmaceutical group focused on the design and early development of new medicines originating from its proprietary GPCR-targeted StaR® technology and Structure-Based Drug Design platform capabilities. We are advancing a broad and deep pipeline of partnered and in-house drug candidates in multiple therapeutic areas including neurology, immuno-oncology, gastroenterology, inflammation and rare/specialty diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sosei Heptaresjapan Flag
    Country
    Country
    Japan
    Address
    Address
    2-1 Kojimachi, Chiyoda-ku Tokyo, Tokyo 1020083
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://soseiheptares.com/?ctry=en
    Linkedin
    Linkedin
    https://in.linkedin.com/company/soseiheptaresco
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nxera Pharma and Shionogi Launch QUVIVIQ in Japan
    Nxera Pharma and Shionogi Launch QUVIVIQ in Japan

    18 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/19/2999496/0/en/Nxera-Pharma-and-Shionogi-Launch-QUVIVIQ-in-Japan-for-Adults-with-Insomnia.html

    GLOBENEWSWIRE
    18 Dec 2024
    Share Share
    Nxera Pharma & Antiverse Collaborate on AI-Driven GPCR Therapies
    Nxera Pharma & Antiverse Collaborate on AI-Driven GPCR Therapies

    05 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/05/2974601/0/en/Nxera-Pharma-and-Antiverse-Enter-Collaboration-To-Design-Novel-GPCR-Targeted-Antibody-Therapeutics-Using-Generative-AI.html

    GLOBENEWSWIRE
    05 Nov 2024
    Share Share
    Nxera Pharma Reports Q3 & 9-Month 2024 Operational Results
    Nxera Pharma Reports Q3 & 9-Month 2024 Operational Results

    01 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/01/2973144/0/en/Nxera-Pharma-Operational-Highlights-and-Consolidated-Results-for-the-Third-Quarter-and-First-Nine-Months-of-2024.html

    GLOBENEWSWIRE
    01 Nov 2024
    Share Share
    Nxera Pharma Wins Biotech Company and Financing Awards 2024
    Nxera Pharma Wins Biotech Company and Financing Awards 2024

    23 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/23/2967497/0/en/Nxera-Pharma-Wins-Biotech-Company-of-the-Year-and-Financing-Deal-of-the-Year-at-the-Citeline-Japan-Awards-2024.html

    GLOBENEWSWIRE
    23 Oct 2024
    Share Share
    Nxera Pharma inks deal with Handok to distribute PIVLAZ in South Korea
    Nxera Pharma inks deal with Handok to distribute PIVLAZ in South Korea

    16 Apr 2024

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/24084/nxera-pharma-inks-deal-with-handok-to-distribute-pivlaz-in-south-korea.html

    BIOSPECTRUM ASIA
    16 Apr 2024
    Share Share
    Nxera Pharma is the New Name for Sosei Group
    Nxera Pharma is the New Name for Sosei Group

    31 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/31/2854969/0/en/Nxera-Pharma-is-the-New-Name-for-Sosei-Group.html

    GLOBENEWSWIRE
    31 Mar 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search